This article discusses the Appeals Court Panel’s decision to uphold the District Court’s ruling that the St. Luke’s-Saltzer acquisition was anticompetitive. The article focuses on the Panel’s views on efficiencies and also comments on its discussion of the implications for ancillary services.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...